Effect of uric acid on coronary microvascular endothelial function in women: Association with eGFR and ADMA

Journal of Atherosclerosis and Thrombosis

Volumn 17, Issue 3, 2010, Pages 259-269

  Kuwahata, So ^a   Hamasaki, Shuichi ^a   Ishida, Sanemasa ^a   Kataoka, Tetsuro ^a   Yoshikawa, Akiko ^a   Orihara, Koji ^a   Ogawa, Masakazu ^a   Oketani, Naoya ^a   Saihara, Keishi ^a   Okui, Hideki ^a   Shinsato, Takuro ^a   Kubozono, Takuro ^a   Ichiki, Hitoshi ^a   Fujita, Shoji ^a   Takumi, Takuro ^a   Yoshino, Satoshi ^a   Nakazaki, Mitsuhiro ^a   Miyata, Masaaki ^a   Tei, Chuwa ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Asymmetric dimethylarginine (ADMA); Endothelial function; Estimated glomerular filtration rate (eGFR); Uric acid

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; ALLOPURINOL; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; N(G),N(G) DIMETHYLARGININE; SPIRONOLACTONE; URIC ACID;

ADULT; AGE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY VASCULAR RESISTANCE; ENDOTHELIAL DYSFUNCTION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; SEX DIFFERENCE; VASCULAR ENDOTHELIUM;

EID: 77951167363     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.1594     Document Type: Article

References (46)

1. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M: Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension, 2003; 41: 1183-1190
2. Culleton BF, Larson MG, Kannel WB, Levy D: Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study. Ann Intern Med, 1999; 131: 7-13
3. Fang J, Alderman MH: Serum uric acid and cardiovascu-lar mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA, 2000; 283: 2404-2410
4. Levine W, Dyer AR, Shekelle RB, Schoenberger JA, Stam-ler J: Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol, 1989; 42: 257-267
5. Freedman DS, Williamson DF, Gunter EW, Byers T: Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol, 1995; 141: 637-644
6. Zoccali C, Maio R, Mallamaci F, Sesti G, Perticone F: Uric acid and endothelial dysfunction in essential hyper-tension. J Am Soc Nephrol, 2006; 17: 1466-1471
7. Vallance P, Leone A, Calver A, Collier J, Moncada S: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet, 1992; 339: 572-575
8. Böger RH, Sydow K, Borlak J, Thum T, Lenzen H, Schubert B, Tsikas D, Bode-Böger SM: LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethi-onine-dependent methyltransferases. Circ Res, 2000; 87: 99-105
9. Kielstein JT, Böger RH, Bode-Böger SM, Frölich JC, Haller H, Ritz E, Fliser D: Marked increase of asymmet-ric dimethylarginine in patients with incipient primary chronic renal disease. J Am Soc Nephrol, 2002; 13: 170-176
10. Chonchol M, Shlipak MG, Katz R, Sarnak MJ, Newman AB, Siscovick DS, Kestenbaum B, Carney JK, Fried LF: Relationship of uric acid with progression of kidney dis-ease. Am J Kidney Dis, 2007; 50: 239-247
11. Nakagawa T, Mazzali M, Kang DH, Kanellis J, Watanabe S, Sanchez-Lozada LG, Rodriguez-Iturbe B, Herrera-Acosta J, Johnson RJ: Hyperuricemia causes glomerular hypertrophy in the rat. Am J Nephrol, 2003; 23: 2-7
12. Lin SD, Tsai DH, Hsu SR: Association between serum uric acid level and components of the metabolic syn-drome. J Chin Med Assoc, 2006; 69: 512-516
13. Johnson RJ, Rideout BA: Uric acid and diet-insights into the epidemic of cardiovascular disease. N Engl J Med, 2004; 350: 1071-1073
14. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A: Long-term follow up of patients with mild coronary artery disease and endothelial dys-function. Circulation, 2000; 101: 948-954
15. Hasdai D, Gibbons RJ, Holmes DR Jr, Higano ST, Ler-man A: Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation, 1997; 96: 3390-3395
16. Suwaidi JA, Higano ST, Holmes DR Jr, Lennon R, Ler-man A: Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol, 2001; 37: 1523-1528
17. Fukuda Y, Teragawa H, Matsuda K, Yamagata T, Matsu-ura H, Chayama K: Tetrahydrobiopterin restores endo-thelial function of coronary arteries in patients with hypercholesterolaemia. Heart, 2002; 87: 264-269
18. Egashira K, Inou T, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Kuga T, Urabe Y, Takeshita A: Effects of age on endothelium-dependent vasodilation of resistance coro-nary artery by acetylcholine in humans. Circulation, 1993; 88: 77-81
19. Doucette JW, Corl PD, Payne HM, Flynn AE, Goto M, Nassi M, Segal J: Validation of a Doppler guide wire for intravascular measurement of coronary artery flow veloc-ity. Circulation, 1992; 85: 1899-1911
20. Ishida S, Hamasaki S, Kamekou M, Yoshitama T, Nakano F, Yoshikawa A, Kataoka T, Saihara K, Minagoe S, Tei C: Advancing age is associated with diminished vascular remodeling and impaired vasodilation in resistance coro-nary arteries. Coron Artery Dis, 2003; 14: 443-449
21. Hamasaki S, Higano ST, Suwaidi JA, Nishimura RA, Miyauchi K, Holmes DR Jr, Lerman A: Cholesterol-low-ering treatment is associated with improvement in coro-nary vascular remodeling and endothelial function in patients with normal or mildly diseased coronary arteries. Arterioscler Thromb Vasc Biol, 2000; 20: 737-743
22. Kataoka T, Hamasaki S, Ishida S, Saihara K, Okui H, Fukudome T, Shinsato T, Mizoguchi E, Ninomiya Y, Otsuji Y, Minagoe S, Tei C: Contribution of increased minimal coronary resistance and attenuated vascular adaptive remodeling to myocardial ischemia in patients with systemic hypertension and ventricular hypertrophy. Am J Cardiol, 2004; 94: 484-487
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabe-tologia, 1985; 28: 412-419
24. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsuka-moto Y, Ito S, Makino H, Hishida A, Matsuo S: Modifi-cation of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis, 2007; 50: 927-937
25. Bode-Böger SM, Böger RH, Kienke S, Junker W, Frölich JC: Elevated L-arginine/dimethylarginine ratio contrib-utes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Bio-phys Res Commun, 1996; 219: 598-603
26. Zar JH: Biostatistical analysis. 2nd ed., Englewood Cliff Prentice-Hall, NJ, 1984
27. Alderman MH, Cohen H, Madhavan S, Kivlighn S: Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension, 1999; 34: 144-150
28. Verdecchia P, Schillaci G, Reboldi GP, Santeusanio F, Por-cellati C, Brunetti P: Relation between serum uric acid and risk of cardiovascular disease in essential hyperten-sion: The PIUMA Study. Hypertension, 2000; 36: 1072-1078
29. Stamp LK, O'Donnell JL, Chapman PT: Emerging thera-pies in the long-term management of hyperuricaemia and gout. Intern Med J, 2007; 37: 258-266
30. Suresh E: Diagnosis and management of gout: a rational approach. Postgrad Med J, 2005; 81: 572-579
31. Matsuura F, Yamashita S, Nakamura T, Nishida M, Nozaki S, Funahashi T, Matsuzawa Y: Effect of visceral fat accu-mulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduc-tion of uric acid than subcutaneous fat obesity. Metabo-lism, 1998; 47: 929-933
32. Fox IH: Metabolic basis for disorders of purine nucleotide degradation. Metabolism, 1981; 30: 616-634
33. Fabregat I, Revilla E, Machado A: Short-term control of the pentose phosphate cycle by insulin could be modu-lated by the NADPH/NADP ratio in rat adipocytes and hepatocytes. Biochem Biophys Res Commun, 1987; 146: 920-925
34. Facchini F, Chen YD, Hollenbeck CB, Reaven GM: Rela-tionship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA, 1991; 266: 3008-3011
35. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtra-tion rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med, 1999; 130: 461-470
36. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S: Significance of hyperuricemia as a risk factor for develop-ing ESRD in a screened cohort. Am J Kidney Dis, 2004; 44: 642-650
37. Cooke JP: Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol, 2000; 20: 2032-2037
38. Valkonen VP, Laakso J, Päivä H, Lehtimäki T, Lakka TA, Isomustajärvi M, Ruokonen I, Salonen JT, Laaksonen R: Asynnetrical dimethylarginine (ADMA) and risk of acute coronary events. Does statin treatment influence plasma ADMA levels? Atheroscler Suppl, 2003; 4: 19-22
39. Kielstein JT, Impraim B, Simmel S, Bode-Böger SM, Tsi-kas D, Frölich JC, Hoeper MM, Haller H, Fliser D: Car-diovascular effects of systemic nitric oxide synthase inhi-bition with asymmetrical dimethylarginine in humans. Circulation, 2004; 109: 172-177
40. Wakabayashi I: Age-related change in relationship between body-mass index, serum sialic acid, and atherogenic risk factors. J Atheroscler Thromb, 1998; 5: 60-65
41. Zavaroni I, Mazza S, Fantuzzi M, Dall'Aglio E, Bonora E, Delsignore R, Passeri M, Reaven GM: Changes in insulin and lipid metabolism in males with asymptomatic hyper-uricaemia. J Intern Med, 1993; 234: 25-30
42. Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, Lee MH, Park JR, Kim H, Rhee EJ, Lee WY, Kim SW, Ryu SH, Keum DG: Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J, 2005; 69: 928-933
43. Cosson E, Pham I, Valensi P, Pariès J, Attali JR, Nitenberg A: Impaired coronary endothelium-dependent vasodila-tion is associated with microalbuminuria in patients with type 2 diabetes and angiographically normal coronary arteries. Diabetes Care, 2006; 29: 107-112
44. Waring WS, Webb DJ, Maxwell SR: Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers. J Cardiovasc Pharmacol, 2001; 38: 365-371
45. Waring WS, McKnight JA, Webb DJ, Maxwell SR: Uric acid restores endothelial function in patients with type 1 diabetes and regular smokers. Diabetes, 2006; 55: 3127-3132
46. Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG: Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis, 2000; 148: 131-139